Centro de Estudios Clínicos SAGA

About Centro de Estudios Clínicos SAGA

Considering the facts surrounding cancer, the Chilean government has promoted the development of clinical trials to face the challenges of this disease. In the last year, 76 protocols / clinical trials have been approved, of which 22% are related to lung cancer, 14% prostatic cancer, 10% malignant melanoma, 9% kidney cancer, and 6% gastric cancer. Saga represents the effort of a group of professionals with broad experience in oncological clinical trials, understanding the need to provide an alternative to cancer patients seeking the best way to match clinical trials with them. For this reason, Saga has established an important network with the oncological community in the country. Saga represents an interesting and attractive partner for the development of oncological clinical trials not only in Chile but also in Latin America.